Nicotinic acid in the treatment of schizophrenias. Canadian Mental Health Association collaborative study: progress report II.
D000293:Adolescent; D000328:Adult; D002170:Canada; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000008:administration & dosage / Q000627:therapeutic use*; D010640:Phenothiazines / Q000627:therapeutic use*; D010919:Placebos; D012559:Schizophrenia / Q000188:drug therapy* / Q000517:prevention & control
D009539:Nicotinic Acids; D010640:Phenothiazines; D010919:Placebos